Homework Help is Here – Start Your Trial Now!
Business
Accounting
As part of its stock-based compensation package, International Electronics granted 52 million stock appreciation rights (SARS) to top officers on January 1, 2024. • At exercise, holders of the SARS are entitled to receive cash or stock equal in value to the excess of the market price at exercise over the share price at the date of grant. • The SARS cannot be exercised until the end of 2027 (vesting date) and expire at the end of 2029. • The $1 par common shares have a market price of $62 per share on the grant date. O The fair value of the SARS, estimated by an appropriate option pricing model, is $6.50 per SAR at January 1, 2024. The fair value re-estimated at December 31, 2024, 2025, 2026, 2027, and 2028, is $7.50, $6.50, $6, $1.90, and $3.00, respectively. • All recipients are expected to remain employed through the vesting date. Required: 1. to 3. Prepare the appropriate journal entries pertaining to the SARS on January 1, 2024 and December 31, 2024-December 31, 2027. The SARS remain unexercised on December 31, 2028, prepare the appropriate entry. 4. The SARs are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. es Complete this question by entering your answers in the tabs below. Req 1 to 3 Req 4 The SARS are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. Note: If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Do not round Intermediate calculations. Enter your answers in millions rounded to 1 decimal place (1.e., 5,500,000 should be entered as 5.5). Show less A

As part of its stock-based compensation package, International Electronics granted 52 million stock appreciation rights (SARS) to top officers on January 1, 2024. • At exercise, holders of the SARS are entitled to receive cash or stock equal in value to the excess of the market price at exercise over the share price at the date of grant. • The SARS cannot be exercised until the end of 2027 (vesting date) and expire at the end of 2029. • The $1 par common shares have a market price of $62 per share on the grant date. O The fair value of the SARS, estimated by an appropriate option pricing model, is $6.50 per SAR at January 1, 2024. The fair value re-estimated at December 31, 2024, 2025, 2026, 2027, and 2028, is $7.50, $6.50, $6, $1.90, and $3.00, respectively. • All recipients are expected to remain employed through the vesting date. Required: 1. to 3. Prepare the appropriate journal entries pertaining to the SARS on January 1, 2024 and December 31, 2024-December 31, 2027. The SARS remain unexercised on December 31, 2028, prepare the appropriate entry. 4. The SARs are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. es Complete this question by entering your answers in the tabs below. Req 1 to 3 Req 4 The SARS are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. Note: If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Do not round Intermediate calculations. Enter your answers in millions rounded to 1 decimal place (1.e., 5,500,000 should be entered as 5.5). Show less A

FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
See similar textbooks
icon
Related questions
Question
As part of its stock-based compensation package, International Electronics granted 52 million stock appreciation rights (SARS) to top officers on January 1, 2024. • At exercise, holders of the SARS are entitled to receive cash or stock equal in value to the excess of the market price at exercise over the share price at the date of grant. • The SARS cannot be exercised until the end of 2027 (vesting date) and expire at the end of 2029. • The $1 par common shares have a market price of $62 per share on the grant date. O The fair value of the SARS, estimated by an appropriate option pricing model, is $6.50 per SAR at January 1, 2024. The fair value re-estimated at December 31, 2024, 2025, 2026, 2027, and 2028, is $7.50, $6.50, $6, $1.90, and $3.00, respectively. • All recipients are expected to remain employed through the vesting date. Required: 1. to 3. Prepare the appropriate journal entries pertaining to the SARS on January 1, 2024 and December 31, 2024-December 31, 2027. The SARS remain unexercised on December 31, 2028, prepare the appropriate entry. 4. The SARs are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. es Complete this question by entering your answers in the tabs below. Req 1 to 3 Req 4 The SARS are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. Note: If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Do not round Intermediate calculations. Enter your answers in millions rounded to 1 decimal place (1.e., 5,500,000 should be entered as 5.5). Show less A
Transcribed Image Text:As part of its stock-based compensation package, International Electronics granted 52 million stock appreciation rights (SARS) to top officers on January 1, 2024. • At exercise, holders of the SARS are entitled to receive cash or stock equal in value to the excess of the market price at exercise over the share price at the date of grant. • The SARS cannot be exercised until the end of 2027 (vesting date) and expire at the end of 2029. • The $1 par common shares have a market price of $62 per share on the grant date. O The fair value of the SARS, estimated by an appropriate option pricing model, is $6.50 per SAR at January 1, 2024. The fair value re-estimated at December 31, 2024, 2025, 2026, 2027, and 2028, is $7.50, $6.50, $6, $1.90, and $3.00, respectively. • All recipients are expected to remain employed through the vesting date. Required: 1. to 3. Prepare the appropriate journal entries pertaining to the SARS on January 1, 2024 and December 31, 2024-December 31, 2027. The SARS remain unexercised on December 31, 2028, prepare the appropriate entry. 4. The SARs are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. es Complete this question by entering your answers in the tabs below. Req 1 to 3 Req 4 The SARS are exercised on June 6, 2029, when the share price is $66, and executives choose to receive the market price appreciation in cash. Prepare the appropriate journal entry(s) on that date. Note: If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Do not round Intermediate calculations. Enter your answers in millions rounded to 1 decimal place (1.e., 5,500,000 should be entered as 5.5). Show less A
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education
SEE MORE TEXTBOOKS